Takeda Pharmaceutical Li... (TAK)
NYSE: TAK
· Real-Time Price · USD
14.97
0.17 (1.15%)
At close: Aug 15, 2025, 9:58 AM
Takeda Pharmaceutical Income Statement
Financials in JPY. Fiscal
year is
April - March.
Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Revenue | 4,581.6B | 4,579B | 4,546.1B | 4,413.1B | 4,263.8B | 4,169B | 4,154.4B | 4,113.6B | 4,027.5B | 3,944.6B | 3,749.4B | 3,591.9B | 3,569B | 3,466B | 3,401.4B | 3,345.6B |
Cost of Revenue | 1,885.5B | 2,072.6B | 2,035.2B | 1,842.1B | 1,613.4B | 1,353.9B | 1,310.4B | 1,272.3B | 1,244.1B | 1,242.7B | 1,188.1B | 1,158.5B | 1,106.8B | 1,051.9B | 1,023.6B | 997.49B |
Gross Profit | 2,696.1B | 2,506.4B | 2,510.8B | 2,571B | 2,650.3B | 2,815.1B | 2,844B | 2,841.3B | 2,783.4B | 2,701.9B | 2,561.2B | 2,433.4B | 2,462.2B | 2,414.1B | 2,377.8B | 2,348.1B |
Operating Income | 396B | 471.44B | 509.41B | 275.82B | 224.68B | 312.71B | 354.78B | 508.56B | 490.5B | 400.32B | 369.82B | 362.81B | 460.84B | 613B | 639.66B | 590.54B |
Interest Income | 34.79B | 40.78B | 62.57B | 67.82B | 63.59B | 65.39B | 85.28B | 90.7B | 125.17B | 117.39B | 79.85B | 71.93B | 56.86B | 104.35B | 128.61B | 131.76B |
Pretax Income | 175.79B | 231.83B | 266.68B | 51.33B | 49.05B | 148.23B | 194.12B | 354.65B | 375.09B | 273.13B | 238.17B | 235.07B | 302.57B | 487.5B | 525.1B | 458.92B |
Net Income | 107.88B | 208.06B | 290B | 149.92B | 144.07B | 178.22B | 191.63B | 301.4B | 317.02B | 274.52B | 213.17B | 197.39B | 230.06B | 438.52B | 473.11B | 431.18B |
Selling & General & Admin | 1,104.8B | 1,094.1B | 1,091.1B | 1,075.7B | 1,053.8B | 1,023.4B | 1,018.2B | 1,013.9B | 997.31B | 965.94B | 934.72B | 898B | 886.36B | 897.32B | 888.89B | 893.13B |
Research & Development | 730.22B | 710.08B | 727.26B | 735.65B | 729.92B | 695.01B | 682.26B | 652.46B | 633.33B | 616.01B | 569.76B | 547.21B | 526.09B | 495.75B | 484.94B | 471.49B |
Other Expenses | 453.83B | 219.53B | -1.21B | -1.21B | -1.21B | -1.21B | -1.01B | -1.01B | 152.97B | 352.44B | 497.4B | 625.38B | 588.87B | 578.97B | 535.28B | 563.87B |
Operating Expenses | 2,288.8B | 2,023.7B | 2,028.7B | 2,333.7B | 2,464.2B | 2,540.9B | 2,489.2B | 2,332.8B | 2,292.9B | 2,301.6B | 2,191.4B | 2,070.6B | 2,001.3B | 1,801.1B | 1,738.1B | 1,757.5B |
Interest Expense | 128.15B | 175.33B | 241.9B | 219.97B | 219.85B | 215.6B | 228.78B | 236.06B | 231.95B | 189.02B | 155.98B | 141.85B | 157.45B | 232.69B | 248.66B | 272.85B |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4,174.3B | 4,096.4B | 4,064B | 4,175.8B | 4,077.6B | 3,894.8B | 3,799.6B | 3,605.1B | 3,537B | 3,544.3B | 3,379.5B | 3,229.1B | 3,108.2B | 2,853B | 2,761.8B | 2,755B |
Income Tax Expense | 66.94B | 26.61B | -20.45B | -95.73B | -91.41B | -30.1B | 2.4B | 53.23B | 58.05B | -1.4B | 24.97B | 37.6B | 72.41B | 48.81B | 51.8B | 27.54B |
Shares Outstanding (Basic) | 3.16B | 3.17B | 3.17B | 3.14B | 3.14B | 3.14B | 3.13B | 3.11B | 3.11B | 3.11B | 3.1B | 3.09B | 3.11B | 3.13B | 3.14B | 3.09B |
Shares Outstanding (Diluted) | 3.16B | 3.17B | 3.22B | 3.18B | 3.14B | 3.17B | 3.13B | 3.13B | 3.23B | 3.14B | 3.13B | 3.11B | 3.15B | 3.15B | 3.16B | 3.11B |
EPS (Basic) | 34.31 | 65.97 | 92.16 | 47.75 | 46.15 | 57.12 | 61.75 | 96.97 | 102.19 | 88.52 | 68.66 | 63.39 | 73.96 | 140.65 | 151.74 | 138.41 |
EPS (Diluted) | 33.44 | 65.10 | 90.95 | 47.02 | 45.61 | 56.22 | 60.80 | 95.88 | 101.10 | 87.85 | 68.26 | 63.06 | 73.57 | 140.21 | 151.17 | 137.92 |
EBITDA | 1,139.1B | 1,145.1B | 1,244.1B | 1,064.1B | 1,027.4B | 1,097.9B | 1,129.8B | 1,201.8B | 1,176.9B | 1,050.6B | 990.48B | 956.28B | 1,024.8B | 1,230.8B | 1,279.3B | 1,239.3B |
EBIT | 381.67B | 289.52B | 411.3B | 185.51B | 183.83B | 322.6B | 381.68B | 537.99B | 554.32B | 495.33B | 427.33B | 410.1B | 493.2B | 602.36B | 626.61B | 573.78B |
Depreciation & Amortization | 761.4B | 758.37B | 758.48B | 806.27B | 785.55B | 760.21B | 750.03B | 677.62B | 664.4B | 655.26B | 625.67B | 598.49B | 583.15B | 570.27B | 562.74B | 561.03B |